The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
A Syrian man is convicted of stabbing a Spanish tourist at Berlin’s Holocaust Memorial
BERLIN -- A court convicted a Syrian man on...
6 US service members killed in Kuwait drone strike
A soldier who “made you feel important,” a mother...
HBO Max and Paramount+ Will Be Merged Into One Service
Now that Paramount has made a deal to purchase...
Eurozone Retail Sales Decline Unexpectedly
Eurozone retail sales fell unexpectedly in January, despite an...